Emergent BioSolutions Inc. (EBS) — Total Liabilities

Annual figures by fiscal year, from SEC filings.

2010: $126.76M2011: $130.14M2012: $122.10M2013: $137.47M2014: $385.49M2015: $377.47M2016: $373.91M2017: $157.90M2018: $1.22B2019: $1.24B2020: $1.44B2021: $1.35B2022: $1.78B2023: $1.17B2024: $906.90M2025: $796.00M$796.00M
2010Total Liabilities (USD)2025
Fiscal YearTotal LiabilitiesChange YoY
2025$796.00M-12.2%
2024$906.90M-22.7%
2023$1.17B-34.0%
2022$1.78B+32.1%
2021$1.35B-6.3%
2020$1.44B+15.9%
2019$1.24B+1.7%
2018$1.22B+671.7%
2017$157.90M-57.8%
2016$373.91M-0.9%
2015$377.47M-2.1%
2014$385.49M+180.4%
2013$137.47M+12.6%
2012$122.10M-6.2%
2011$130.14M+2.7%
2010$126.76M